Icagen (ICGND) Gross Profit Margin starting from the third quarter 2019 to third quarter 2018, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Icagen, Inc.  (ICGND)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Icagen's Gross Profit Margin by quarter

Trends, Rankings, Statistics



ICGND Gross Profit Margin (Sep 30 2019)
Q3
(Jun 30 2019)
Q2
(Mar 31 2019)
Q1
(Dec 31 2018)
Q4
(Sep 30 2018)
Q3
Y / Y Revenue Change 19.66 %
Seq. Revenue Change -7.84 %
Revenue In Millions $3.60
Gross Profit Margin 13.62 %
Gross Profit Margin Total Ranking # 3596
Gross Profit In Millions $0.49
Y / Y Gross Profit Change -69.94 %
Seq. Gross Profit Change -49.95 %


Commenting Third Quarter 2019 Gross Profit Margin
Icagen, Inc. experienced contraction in Gross Profit by -49.95 % to $4 millions and Revenue by -7.84 %, while Gross Profit Margin fell to 13.62 %, below company*s average Gross Profit Margin.


Observing third quarter 2019 results within Medical Laboratories industry 28 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 3102 to 3596.
Learn about Gross Margin
ICGND's Gross Profit Margin third quarter 2019 Company Ranking
Within: No.
Medical Laboratories Industry # 29
Healthcare Sector # 461
Overall # 3491

Gross Profit Margin Statistics
High Average Low
57.39 % 34 % 3.41 %
(Dec 31 2017)  




Other Gross Profit Margin Profitability Ratios
ICGND's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ICGND's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ICGND's Competitors
Gross Profit Margin Profit Margin for Icagen's Suppliers
Gross Profit Margin Profit Margin for ICGND's Customers

You may also want to know
ICGND's Annual Growth Rates ICGND's Profitability Ratios ICGND's Asset Turnover Ratio ICGND's Dividend Growth
ICGND's Roe ICGND's Valuation Ratios ICGND's Financial Strength Ratios ICGND's Gross Profit Growth
ICGND's Roa ICGND's Inventory Turnover Ratio ICGND's Growth Rates ICGND's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2019, within Medical Laboratories Industry Gross Profit MarginSep 30 2019 MRQ Gross ProfitSep 30 2019 MRQ Revenue
Quest Diagnostics Inc  35.38 %$ 692.000  Millions$ 1,956.000  Millions
American Shared Hospital Services  34.20 %$ 1.813  Millions$ 5.301  Millions
Iqvia Holdings Inc   33.12 %$ 917.000  Millions$ 2,769.000  Millions
Personalis Inc   32.82 %$ 5.629  Millions$ 17.153  Millions
Inotiv Inc   32.54 %$ 4.812  Millions$ 14.786  Millions
Bionexus Gene Lab Corp   31.75 %$ 0.008  Millions$ 0.024  Millions
Medpace Holdings Inc   29.67 %$ 64.168  Millions$ 216.238  Millions
Hologic Inc  28.82 %$ 249.500  Millions$ 865.800  Millions
Labcorp Holdings Inc   27.91 %$ 817.300  Millions$ 2,928.500  Millions
Syneos Health Inc   22.37 %$ 263.354  Millions$ 1,177.028  Millions
Kushco Holdings Inc   20.06 %$ 9.421  Millions$ 46.972  Millions
Icagen, Inc.  13.62 %$ 0.490  Millions$ 3.599  Millions
Radnet Inc   13.09 %$ 38.309  Millions$ 292.692  Millions
U s Stem Cell Inc   12.28 %$ 0.019  Millions$ 0.157  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.